BDPT
BIOADAPTIVES, INC.Company Information
- Company Name
- BIOADAPTIVES, INC.
- CIK
- CIK0001575142
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BDPT: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BDPT
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-11-22
- Last sale
- —
- Shares purchased (TTM)
- 125,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- -17.10%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets New | ||||||||||||||||||
| Series C Preferred Stock | - | - | - | - | - | - | 1 | - | - | - | 1 | - | ||||||
| Series D Preferred Stock | - | - | - | - | - | - | 20 | - | - | - | 20 | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Marketable Securities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Assets | ||||||||||||||||||
| Accounts Payable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accounts Receivable Net | - | - | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Other Receivables | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Indefinite Lived License Agreements | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Convertible Notes Payable | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | 0 | - | ||||||
| Other Liabilities Current | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -2 | -2 | -2 | -1 | -1 | -2 | -1 | -2 | -2 | -2 | -2 | -1 | ||||||
| Additional Paid In Capital | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | ||||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | -0 | -0 | -0 | -0 | -0 | -0 | -0 | - | - | - | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -11 | -11 | -11 | -10 | -10 | -9 | -9 | -9 | -9 | -9 | -8 | -8 | ||||||
| Debt Instrument Unamortized Discount | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 31 | 31 | 31 | 31 | 31 | 10 | 31 | 10 | 10 | 10 | 10 | 10 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | ||||||
| Common Stock Shares Issued | 37 | 12 | 12 | 11 | 10 | 9 | 8 | 1,232 | 1,232 | 1,155 | 6 | 776 | ||||||
| Shares Outstanding | 37 | 12 | 12 | 11 | 10 | 9 | 8 | 1,232 | 1,232 | 1,155 | 6 | 776 | ||||||
| Common Stock Capital Shares Reserved For Future Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOADAPTIVES, INC. (BDPT) — SEC Financial Statements & Analysis
BIOADAPTIVES, INC. (BDPT) is a pharmaceutical preparations company, incorporated in DE. BIOADAPTIVES, INC. trades on OTC as: BDPT. BIOADAPTIVES, INC. (BDPT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, BIOADAPTIVES, INC. carries a market cap of $41.16K, a P/E ratio of -0.04x, a P/B ratio of -0.02x, a P/S ratio of 1.61x, an enterprise value of $534.66K, and an EV/EBITDA multiple of -0.59x. On profitability, it posts a gross margin of 77.41%, an operating margin of -3556.98%, a net margin of -4553.20%, a Return on Equity (ROE) of 80.23%, and a Return on Assets (ROA) of -662.63%. Per share, it reports EPS of $-0.08, diluted EPS of $-0.00, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 694.07% year-over-year, net income growth of 52.24% year-over-year, and EPS growth of 2.26% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.02x, working capital of $-1.78M, a debt-to-equity ratio of -1.04x, a debt ratio of 23.42, an interest coverage ratio of -4.01x, free cash flow of $-436.36K (TTM), and net debt of $493.50K. Figures sourced from SEC EDGAR.
- Market Cap
- $41.16K
- P/E TTM
- -0.04x
- EPS TTM
- $-0.08
- P/B TTM
- -0.02x
- ROE TTM
- 80.23%
- ROA TTM
- -662.63%
- Debt To Equity
- -1.04x
- Free Cash Flow TTM
- $-436.36K
- Net Revenue TTM Growth 1Y
- 694.07%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOADAPTIVES, INC. in?
BIOADAPTIVES, INC. (BDPT) operates in the Pharmaceutical Preparations industry.
What exchange does BDPT trade on?
BIOADAPTIVES, INC. (BDPT) trades on the OTC.
Where is BIOADAPTIVES, INC. incorporated?
BIOADAPTIVES, INC. is incorporated in DE.
When was BIOADAPTIVES, INC. (BDPT)'s most recent SEC filing?
BIOADAPTIVES, INC. (BDPT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is BDPT's market cap?
BIOADAPTIVES, INC. (BDPT) has a market capitalization of $41.16K as of 2026-06-30.
What is BDPT's EPS (earnings per share)?
BIOADAPTIVES, INC. (BDPT)'s trailing twelve month EPS is $-0.08 as of 2026-06-30.
What is BDPT's ROE (return on equity)?
BIOADAPTIVES, INC. (BDPT)'s trailing twelve month Return on Equity (ROE) is 80.23% as of 2026-06-30.
What is BDPT's ROA (return on assets)?
BIOADAPTIVES, INC. (BDPT)'s trailing twelve month Return on Assets (ROA) is -662.63% as of 2026-06-30.
What is BDPT's EV/EBITDA?
BIOADAPTIVES, INC. (BDPT)'s trailing twelve month EV/EBITDA is -0.59x as of 2026-06-30.